Clinical Safety of Combined Targeted and Viscum album L. Therapy in Oncological Patients
Background: Despite improvement of tumor response rates, targeted therapy may induce toxicities in cancer patients. Recent studies indicate amelioration of adverse events (AEs) by add-on mistletoe (Viscum album L., VA) in standard oncological treatment. The primary objective of this multicenter obse...
Main Authors: | Anja Thronicke, Shiao Li Oei, Antje Merkle, Harald Matthes, Friedemann Schad |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2018-09-01
|
Series: | Medicines |
Subjects: | |
Online Access: | http://www.mdpi.com/2305-6320/5/3/100 |
Similar Items
-
Clinical safety of combined therapy of immune checkpoint inhibitors and Viscum album L. therapy in patients with advanced or metastatic cancer
by: Anja Thronicke, et al.
Published: (2017-12-01) -
Chemical Pleurodesis Using Doxycycline and Viscum album Extract
by: Kyung Sub Song, et al.
Published: (2017-08-01) -
Tratamento integrativo homeopático e farmacopuntura com Viscum album em carcinoma mamário canino: Relato de caso
by: Luiz Carlos de Lucena Júnior, et al.
Published: (2021-06-01) -
The Effects of Aqueous, Alcoholic and Acetone Extracts of Viscum album on Fibroblast Cell Proliferation in Cell Culture
by: Tahereh Naji, et al.
Published: (2019-01-01) -
The most significant parasitic and saprophytic fungi on common mistletoe (Viscum album L) and their potential application in biocontrol
by: Karadžić Dragan, et al.
Published: (2004-01-01)